Achillion Pharmaceuticals (ACHN) Prices 15M Shares at $8.40

Article Stock Quotes (1) Comments (0)

Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) priced an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $8.40 per share. The net proceeds to Achillion from the sale of the shares, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $118.5 million. The offering is expected to close on February 27, 2013, subject to customary closing conditions. Citigroup and Leerink Swann LLC are acting as joint book-running managers, and JMP Securities LLC, Piper Jaffray & Co. and Wells Fargo Securities, LLC are acting as co-managers for the offering.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Combimatrix (CBMX) Files 1.06M Common Shelf for Shareholders
• Tesla (TSLA) convertible note sale raised from $525 million to $600 million - DJ
• Rockwell Medical (RMTI) Prices 11.5M Common Stock Offering

Create E-mail Alert Related Categories

Equity Offerings

Related Entities

Piper Jaffray, Citi, JMP Securities, Wells Fargo

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?